Focuses on the tolerability of oral therapy for hemophilia with inhibitors. Administration of factor VIII (fVIII) in the treatment of hemophilia patients; Disadvantages of the fVIII infusion on pediatric patients; Use of synergists to increase the efficacy of oral tolerance therapy.